High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$13.5M
$13,460,090
Total Sells (Filtered)
$17.2M
$17,212,370
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-09 | $319,059 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-09 | $111,045 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-05 | $23,700 | P | Form 4 |
|
WGS
P
GeneDx Holdings Corp.
Meister Keith A.
• Director
Discretionary Buy
2026-03-05
$3,836,033Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-05 | $3,836,033Large | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-05 | $155,532 | P | Form 4 |
|
WGS
P
GeneDx Holdings Corp.
Meister Keith A.
• Director
Discretionary Buy
2026-03-05
$2,399,106Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-05 | $2,399,106Large | P | Form 4 |
|
WGS
P
GeneDx Holdings Corp.
Meister Keith A.
• Director
Discretionary Buy
2026-03-05
$4,954,782Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-05 | $4,954,782Large | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -10.8%
|
2026-03-04 | $199,897 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-04 | $454,967 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -18.0%
|
2026-03-04 | $822,621 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -19.1%
|
2026-03-04 | $723,783 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-04 | $110,540 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -10.6%
|
2026-03-04 | $175,933 | S | Form 4 |
|
WGS
P
GeneDx Holdings Corp.
Meister Keith A.
• Director
Discretionary Buy
2026-03-03
$1,384,713Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-03 | $1,384,713Large | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-03 | $69,683 | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-03 | $18,922 | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-03 | $14,400 | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Buy
|
2026-03-03 | $603,220 | P | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-02 | $22,248 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -62.1%
|
2026-02-04 | $29,082 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -50.0%
|
2026-02-04 | $9,045 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-02-04 | $64,684 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -27.5%
|
2026-02-04 | $119,456 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -27.5%
|
2026-02-04 | $87,816 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -22.9%
|
2026-02-04 | $53,796 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -74.9%
|
2026-02-04 | $137,804 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 Sell
|
2026-02-04 | $9,192 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
Sell to CoverΔOwn -16.4%
|
2026-02-02 | $116,967 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
Sell to Cover
|
2026-02-02 | $48,517 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
Sell to Cover
|
2026-02-02 | $8,999 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
Sell to CoverΔOwn -18.9%
|
2026-02-02 | $165,198 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-01-29 | $29,610 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-01-29 | $184 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-01-29 | $155,375 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $49,170 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $51,265 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $144,425 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -11.3%
|
2025-12-16 | $378,287 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $85,840 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $135,617 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $236,640 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -11.0%
|
2025-12-16 | $289,449 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $138,448 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $40,880 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $11,156 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $50,178 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $18,200 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $51,270 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $134,286 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $30,556 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $48,187 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $84,016 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $102,703 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $14,472 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $3,920 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $17,837 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -36.5%
|
2025-12-09 | $579,620 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -19.0%
|
2025-12-09 | $201,648 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-01 | $61,276 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $23,820 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $117,964 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $1,810,437Large | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $1,435,059Large | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $1,000,093Large | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $319,342 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $365,504 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $289,611 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $201,962 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $64,470 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $11,667 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $180,012 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $142,640 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $99,547 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $31,839 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -38.5%
|
2025-10-29 | $294,107 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-10-29 | $547 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-10-29 | $52,978 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -13.1%
|
2025-09-30 | $58,204 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $41,354 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $46,330 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $36,203 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Other
|
2025-09-30 | $40,707 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -32.8%
|
2025-09-30 | $233,851 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -25.8%
|
2025-09-30 | $72,134 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $22,046 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -17.0%
|
2025-09-30 | $60,458 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -61.3%
|
2025-09-30 | $560,457 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 SellΔOwn -34.6%
|
2025-09-30 | $480,160 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $116,506 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $63,690 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $15,460 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -29.3%
|
2025-09-30 | $292,361 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $7,958 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -29.9%
|
2025-09-16 | $452,850 | S | Form 4 |
|
WGS
S
GeneDx Holdings Corp.
Stueland Katherine
• CEO
Sell to CoverΔOwn -41.9%
2025-09-16
$1,275,585Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -41.9%
|
2025-09-16 | $1,275,585Large | S | Form 4 |